WHO and Eli Lilly Combat Surge of Fake Weight Loss Drugs

The World Health Organization has issued a global alert about counterfeit versions of Ozempic, a drug primarily used to treat type 2 diabetes but also popular for weight loss. The fake drugs, which have been seized in the UK, US, and Brazil, pose significant health risks as they may not contain the active ingredient semaglutide or could contain other medications like insulin. The WHO advises sourcing the drug only through reputable channels to avoid these dangers.